TCI GENE Common Stock

TCI GENE (6879.TWO) currently reports a common stock of $260M as of June 2026. That compares with $260M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore TCI GENE's common stock history and peer comparisons.

TCI GENE's common stock was unchanged from $260M to $260M — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TCI GENE reported $260M in common stock as of June 2026. That compares with $260M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $260M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TCI GENE, and consider following 6879.TWO for alerts when major investors trade the stock.

TCI GENE is classified in the Healthcare sector. On common stock, it currently shows $260M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6879.TWO with unrelated industries.